Tumor Budding May Predict Survival in Head and Neck Cancer
August 14, 2025
-
3 min
A study involving 98 patients with head and neck squamous cell carcinoma revealed that high tumor budding is significantly associated with worse prognosis and increased lymph node metastasis. Patients with more than four tumor buds had a 5-year overall survival rate of just 26%, compared to 85% for those with low tumor budding. This biomarker was identified as an independent predictor of survival, enhancing awareness of disease aggressiveness. The study emphasizes the potential for tumor budding to aid in treatment decisions, particularly regarding neck dissection.
1. High tumor budding correlates with poor prognosis in head and neck squamous cell carcinoma. 2. 26% survival rate for high tumor budding vs. 85% for low. 3. Optimal cutoff for buds is 4.5. 4. Independently predicts overall survival and lymph node metastasis. 5. Requires validation in larger studies. 6. Associated with aggressive cancer features. 7. Practical marker for guiding treatment decisions.
Listen Tab content